ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,390Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 2343

$1.38M Total Retail Price of All Prescriptions

Rank: 31 out of 2343

682 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 682 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 682 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 21,151 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 977 879 1 8
FUROSEMIDE 932 879 2 6
LEVOTHYROXINE SODIUM 871 731 3 2
SIMVASTATIN 805 678 4 1
OMEPRAZOLE 727 603 5 4
CITALOPRAM HBR 590 522 6 17
METOPROLOL TARTRATE 490 418 7 7
METOPROLOL SUCCINATE 473 447 8 14
LISINOPRIL 438 368 9 3
AMLODIPINE BESYLATE 435 390 10 5
DONEPEZIL HCL 409 393 11 21
TRAZODONE HCL 339 321 12 53
KLOR-CON M20 320 284 13 44
MIRTAZAPINE 306 286 14 41
GABAPENTIN 287 207 15 16
DIGOXIN 272 249 16 35
METFORMIN HCL 260 212 17 9
CLOPIDOGREL 256 223 18 26
TRAMADOL HCL 251 227 19 25
OXYCODONE-ACETAMINOPHEN 236 178 S2 20 49
SERTRALINE HCL 234 212 21 20
NAMENDA 233 225 22 36
RISPERIDONE 232 184 23 61
POTASSIUM CHLORIDE 231 225 24 18
HYDROCODONE-ACETAMINOPHEN 229 143 S3 25 13
ATORVASTATIN CALCIUM 227 198 26 10
PANTOPRAZOLE SODIUM 206 188 27 22
ZOLPIDEM TARTRATE 198 133 28 24
LEVETIRACETAM 188 109 29 104
ALLOPURINOL 187 164 30 31
ESCITALOPRAM OXALATE 183 123 31 55
LANTUS 182 144 32 51
TAMSULOSIN HCL 168 141 33 29
VENLAFAXINE HCL ER 168 98 33 87
GLIMEPIRIDE 167 146 35 45
PLAVIX 165 154 36 38
HYDROCHLOROTHIAZIDE 156 147 37 11
QUETIAPINE FUMARATE 154 146 38 77
ATENOLOL 154 148 38 12
ALBUTEROL SULFATE 153 152 40 126
SULFAMETHOXAZOLE-TRIMETHOPRIM 146 125 41 120
LANTUS SOLOSTAR 143 101 42 101
GLIPIZIDE 143 139 42 56
NOVOLIN R 135 117 44 227
CARVEDILOL 131 116 45 27
BUSPIRONE HCL 130 102 46 146
JANUVIA 129 79 47 50
CLONIDINE HCL 126 125 48 70
MELOXICAM 126 97 48 68
DIVALPROEX SODIUM 125 88 50 105
DIOVAN 125 118 50 23
CEPHALEXIN 124 104 52 111
ISOSORBIDE MONONITRATE ER 123 123 53 32
ADVAIR DISKUS 119 100 54 34
NEXIUM 119 103 54 33
CELEBREX 118 114 56 71
CARBIDOPA-LEVODOPA 115 92 57 85
FLUTICASONE PROPIONATE 115 91 57 46
OXYBUTYNIN CHLORIDE ER 114 82 59 149
SPIRONOLACTONE 114 100 59 65
AZITHROMYCIN 111 104 61 39
IPRATROPIUM-ALBUTEROL 111 111 61 99
LOSARTAN POTASSIUM 111 95 61 19
CIPROFLOXACIN HCL 107 79 64 72
SPIRIVA 107 98 64 48
NEOMYCIN-POLYMYXIN B 104 0 10 66 397
ALENDRONATE SODIUM 103 102 67 28
MECLIZINE HCL 101 87 68 103
PREDNISONE 101 88 68 37
AMLODIPINE BESYLATE-BENAZEPRIL 93 81 70 59
LIPITOR 90 81 71 78
LOSARTAN-HYDROCHLOROTHIAZIDE 88 69 72 64
XARELTO 87 35 73 368
CRESTOR 87 80 73 30
ABILIFY 85 73 75 159
FENTANYL 84 60 S2 76 69
KLOR-CON M10 83 83 77 107
METOCLOPRAMIDE HCL 82 56 78 168
ROPINIROLE HCL 80 63 79 124
PRAVASTATIN SODIUM 73 46 80 15
VALPROIC ACID 73 0 80 261
LEVOFLOXACIN 72 64 82 106
GLIPIZIDE XL 72 65 82 84
CEFUROXIME 72 66 82 193
AMITIZA 71 61 85 304
MORPHINE SULFATE ER 70 32 S2 86 142
PEN NEEDLE 70 59 86 119
HUMALOG 70 52 86 131
SYMBICORT 69 68 89 167
CILOSTAZOL 68 56 90 204
LOVASTATIN 68 60 90 47
INSULIN SYRINGE 67 30 92 102
HYDRALAZINE HCL 67 61 92 92
TIZANIDINE HCL 66 29 94 296
ACETAMINOPHEN-CODEINE 64 39 S3 95 112
HUMULIN R 63 50 96 269
NITROGLYCERIN PATCH 62 61 97 147
DILTIAZEM 24HR ER 62 49 97 76
CALCITONIN-SALMON 62 50 97 323
POLYETHYLENE GLYCOL 3350 62 47 97 54
RANITIDINE HCL 61 61 101 43
SINGULAIR 61 40 101 100
BENAZEPRIL HCL 60 55 103 113
BUPROPION HCL SR 60 60 103 221
NITROFURANTOIN 57 55 105 330
GLIPIZIDE ER 56 56 106 115
BACLOFEN 56 13 106 161
OXYCODONE HCL-ACETAMINOPHEN 56 11 S2 106 136
HUMULIN 70-30 55 55 109 243
LANSOPRAZOLE 55 45 109 162
TRIAMCINOLONE ACETONIDE 55 46 109 137
AMOXICILLIN 54 48 112 118
CYCLOBENZAPRINE HCL 54 0 R 112 109
PROAIR HFA 54 34 112 86
AGGRENOX 54 46 112 174
FINASTERIDE 53 53 116 80
LYRICA 53 21 116 135
DETROL LA 52 48 118 150
LUMIGAN 51 51 119 406
OXYCONTIN 51 0 S2 119 138
VERAPAMIL ER 51 45 119 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.